Life-Space 60 Grams, for 0-36 Month Baby, 7.5 Billion CFU & Multi Strain, Balance Microflora, Supports Digestive Health & Nutrient Absorption & Immunity, No Refrigeration Probiotic Powder for Baby

Life-Space 60 Grams, for 0-36 Month Baby, 7.5 Billion CFU & Multi Strain, Balance Microflora, Supports Digestive Health & Nutrient Absorption & Immunity, No Refrigeration Probiotic Powder for Baby

• 【Balance Microflora】0-36 months babies have not yet established a complete microbial community, and their bodies will suffer from indigestion, non-absorption of nutrients, and low immunity. This probiotic powder helps replenish and balance baby's microflora, providing the essential probiotics needed for growth.
• 【Formulated for 0-36 Months Baby】 With 7.5 billion CFU and a multi-strain formula, our baby probiotic powder builds a strong foundation for gut health in infants and toddlers, promotes tolerance for first foods, maintains intestinal microbiome, and ensures everyday health and wellbeing.
• 【Easy to Take】This probiotic powder is easy to use, 1g (1 level spoon) every day with or without food is good for enhancing the baby's immune health and general well-being.
• 【Storage Instructions】With unique freeze-dry technology, Life-Space probiotics keep the strains dormant until consumed. Store in a cool, dry environment, do not need to be refrigerated. But storing your probiotics in the refrigerator is always a better choice, ensuring long shelf life and maximum benefits.
• 【No.1 Probiotic Brand in Australia】Life-Space Probiotics offers premium probiotic supplements using high-quality, clinically tested ingredients that are naturally sourced, dairy-free, and gluten-free. They contain no artificial flavors or colorants, and no eggs.
• CLINICALLY STUDIED PROBIOTIC STRAINS - Life-Space probiotics feature premium, scientifically validated strains identified by alpha-numeric codes (e.g., Lactobacillus rhamnosus HN001). These codes indicate strains with documented clinical research supporting their safety and efficacy. Probiotic products lacking strain-specific identification (e.g., unnamed "Lactobacillus rhamnosus") have not been clinically evaluated for targeted benefits.